Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
Frontotemporal dementia (FTD) is the second most common cause of dementia in people under the age of 65 years. A large proportion of FTD patients (35-50%) have a family history of dementia, consistent with a strong genetic component to the disease. In 1998, mutations in the gene encoding the microtubule-associated protein tau (MAPT) were shown to cause familial FTD with parkinsonism linked to chromosome 17q21 (FTDP-17). The neuropathology of patients with defined MAPT mutations is characterized by cytoplasmic neurofibrillary inclusions composed of hyperphosphorylated tau. However, in multiple FTD families with significant evidence for linkage to the same region on chromosome 17q21 (D17S1787-D17S806), mutations in MAPT have not been found and the patients consistently lack tau-immunoreactive inclusion pathology. In contrast, these patients have ubiquitin (ub)-immunoreactive neuronal cytoplasmic inclusions and characteristic lentiform ub-immunoreactive neuronal intranuclear inclusions. Here we demonstrate that in these families, FTD is caused by mutations in progranulin (PGRN) that are likely to create null alleles. PGRN is located 1.7 Mb centromeric of MAPT on chromosome 17q21.31 and encodes a 68.5-kDa secreted growth factor involved in the regulation of multiple processes including development, wound repair and inflammation. PGRN has also been strongly linked to tumorigenesis. Moreover, PGRN expression is increased in activated microglia in many neurodegenerative diseases including Creutzfeldt-Jakob disease, motor neuron disease and Alzheimer's disease. Our results identify mutations in PGRN as a cause of neurodegenerative disease and indicate the importance of PGRN function for neuronal survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“has been implicated in frontotemporal dementia in humans and mice”
From Cross-Species Single-Cell Analysis Reveals Divergence of the Primate Microglia Program (2019) · cites this paper as Baker et al., 2006
In the citing paper
“Importantly, while abnormal proteostasis is a hallmark of aging and misfolded proteins are a key feature in both LSDs and neurodegeneration, other macromolecules are processed by the lysosome, evidenced by the finding that both lipid and carbohydrate metabolism are disrupted in these diseases throughout the lifespan.12,13”
From The lysosome and proteostatic stress at the intersection of pediatric neurological disorders and adult neurodegenerative diseases (2025) · cites this paper as [12]
In the citing paper
“Haploinsufficiency of GRN is also associated with frontotemporal lobar degeneration34.”
From Rare variant associations with plasma protein levels in the UK Biobank (2023) · cites this paper as [34]
In the citing paper
“We also identified two lysosomal proteins, GRN and TMEM106B80,81, that are associated with frontotemporal dementia (FTD)82,83 but were also identified in the latest AD risk GWAS23.”
From Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer’s disease (2024) · cites this paper as [83]
In the citing paper
“The most common genes linked to familial FTD are MAPT, progranulin (GRN), and chromosome 9 open reading frame 72 (C9orf72).”
From New developments of biofluid‐based biomarkers for routine diagnosis and disease trajectories in frontotemporal dementia (2022) · cites this paper as [37]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17
Hutton, M., Lendon, C. L., Rizzu, P., Baker, M., Froelich, S., Houlden, H., Pickering-Brown, S., Chakraverty, S., Isaacs, A., Grover, A., et al. (1998) · Nature · doi:10.1038/31508 · Cited by 3,498 · cited 1×
“These include the mitogen-activated protein kinase (MAPK) and phosphatidylinositol-3-OH kinase (PI(3)K) cascades(14,28), both of which regulate crucial functions in neurons.”
BackgroundSelf-citationCruts, M., Gijselinck, I., van der Zee, J., Engelborghs, S., Wils, H., Pirici, D., Rademakers, R., Vandenberghe, R., Dermaut, B., Martin, J.-J., et al. (2006) · Nature · doi:10.1038/nature05017 · Cited by 1,512
Self-citationClinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups.
(1994) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.57.4.416 · Cited by 1,331
Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics
Maquat, L. E. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1310 · Cited by 1,214
ANG mutations segregate with familial and 'sporadic' amyotrophic lateral sclerosis
Greenway, M. J., Andersen, P. M., Russ, C., Ennis, S., Cashman, S., Donaghy, C., Patterson, V., Swingler, R., Kieran, D., Prehn, J., et al. (2006) · Nature Genetics · doi:10.1038/ng1742 · Cited by 667
Frontotemporal dementia and parkinsonism linked to chromosome 17: A consensus conference
Foster, N. L., Wilhelmsen, K., Sima, A. A. F., Jones, M. Z., D'Amato, C. J., Gilman, S., & Participants, C. (1997) · Annals of Neurology · doi:10.1002/ana.410410606 · Cited by 634
Progranulin is a mediator of the wound response
He, Z., Ong, C. H. P., Halper, J., & Bateman, A. (2003) · Nature Medicine · doi:10.1038/nm816 · Cited by 490
He, Z., & Bateman, A. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0474-3 · Cited by 476
Cellular Localization of Gene Expression for Progranulin
Daniel, R., He, Z., Carmichael, K. P., Halper, J., & Bateman, A. (2000) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540004800713 · Cited by 346
Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice
Capsoni, S., Ugolini, G., Comparini, A., Ruberti, F., Berardi, N., & Cattaneo, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6826 · Cited by 277
Research works printed but not linked: 1
- Froelich, S. et al. Mapping of a disease locus for familial rapidly progressive frontotemporal dementia to chromosome 17q12–21. Am. J. Med. Genet. 74, 380–385 (1997) · doi:10.1002/(sici)1096-8628(19970725)74:4<380::aid-ajmg8>3.0.co;2-t
Cited by
Items 101–200 of 1,018
Colombrita, C., Onesto, E., Megiorni, F., Pizzuti, A., Baralle, F. E., Buratti, E., Silani, V., & Ratti, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.333450 · Cited by 292
Semantic dementia: demography, familial factors and survival in a consecutive series of 100 cases
Hodges, J. R., Mitchell, J., Dawson, K., Spillantini, M. G., Xuereb, J. H., McMonagle, P., Nestor, P. J., & Patterson, K. (2010) · Brain · doi:10.1093/brain/awp248 · Cited by 286
The genetics and neuropathology of frontotemporal lobar degeneration
Sieben, A., Van Langenhove, T., Engelborghs, S., Martin, J.-J., Boon, P., Cras, P., De Deyn, P.-P., Santens, P., Van Broeckhoven, C., & Cruts, M. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1029-x · Cited by 280
Understanding microRNAs in neurodegeneration
Eacker, S. M., Dawson, T. M., & Dawson, V. L. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2726 · Cited by 239
FTD and ALS: A Tale of Two Diseases
Ferrari, R., Kapogiannis, D., D. Huey, E., & Momeni, P. (2011) · Current Alzheimer Research · doi:10.2174/156720511795563700 · Cited by 272
The clinical and pathological phenotype of C9ORF72 hexanucleotide repeat expansions
Simón-Sánchez, J., Dopper, E. G. P., Cohn-Hokke, P. E., Hukema, R. K., Nicolaou, N., Seelaar, H., de Graaf, J. R. A., de Koning, I., van Schoor, N. M., Deeg, D. J. H., et al. (2012) · Brain · doi:10.1093/brain/awr353 · Cited by 270
TARDBP and FUS Mutations Associated with Amyotrophic Lateral Sclerosis: Summary and Update
Lattante, S., Rouleau, G. A., & Kabashi, E. (2013) · Human Mutation · doi:10.1002/humu.22319 · Cited by 265
Neurofilament light chain: a biomarker for genetic frontotemporal dementia
Meeter, L. H., Dopper, E. G., Jiskoot, L. C., Sanchez‐Valle, R., Graff, C., Benussi, L., Ghidoni, R., Pijnenburg, Y. A., Borroni, B., Galimberti, D., et al. (2016) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.325 · Cited by 263
Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine
Irwin, D. J., Cairns, N. J., Grossman, M., McMillan, C. T., Lee, E. B., Van Deerlin, V. M., Lee, V. M.-Y., & Trojanowski, J. Q. (2015) · Acta Neuropathologica · doi:10.1007/s00401-014-1380-1 · Cited by 264
Mutations in CHMP2B in Lower Motor Neuron Predominant Amyotrophic Lateral Sclerosis (ALS)
Cox, L. E., Ferraiuolo, L., Goodall, E. F., Heath, P. R., Higginbottom, A., Mortiboys, H., Hollinger, H. C., Hartley, J. A., Brockington, A., Burness, C. E., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009872 · Cited by 262
Rascovsky, K., Hodges, J. R., Kipps, C. M., Johnson, J. K., Seeley, W. W., Mendez, M. F., Knopman, D., Kertesz, A., Mesulam, M., Salmon, D. P., et al. (2007) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0b013e31815c3445 · Cited by 260
Progranulin, lysosomal regulation and neurodegenerative disease
Kao, A. W., McKay, A., Singh, P. P., Brunet, A., & Huang, E. J. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.36 · Cited by 258
Abnormal TDP-43 immunoreactivity in AD modifies clinicopathologic and radiologic phenotype
Josephs, K. A., Whitwell, J. L., Knopman, D. S., Hu, W. T., Stroh, D. A., Baker, M., Rademakers, R., Boeve, B. F., Parisi, J. E., Smith, G. E., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000304041.09418.b1 · Cited by 253
Self-citationAnalysis of alternative splicing associated with aging and neurodegeneration in the human brain
Tollervey, J. R., Wang, Z., Hortobágyi, T., Witten, J. T., Zarnack, K., Kayikci, M., Clark, T. A., Schweitzer, A. C., Rot, G., Curk, T., et al. (2011) · Genome Research · doi:10.1101/gr.122226.111 · Cited by 252
“The prevalence of neurodegenerative diseases increases with age, and molecular processes associated with brain aging contribute to cognitive decline (Bishop et al. 2010).”
BackgroundScherling, C. S., Hall, T., Berisha, F., Klepac, K., Karydas, A., Coppola, G., Kramer, J. H., Rabinovici, G., Ahlijanian, M., Miller, B. L., et al. (2014) · Annals of Neurology · doi:10.1002/ana.24052 · Cited by 249
FUS pathology defines the majority of tau- and TDP-43-negative frontotemporal lobar degeneration
The FReJA Consortium, Urwin, H., Josephs, K. A., Rohrer, J. D., Mackenzie, I. R., Neumann, M., Authier, A., Seelaar, H., Van Swieten, J. C., Brown, J. M., et al. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0698-6 · Cited by 248
Self-citationAlzheimer’s disease phenotypes and genotypes associated with mutations in presenilin 2
Jayadev, S., Leverenz, J. B., Steinbart, E., Stahl, J., Klunk, W., Yu, C.-E., & Bird, T. D. (2010) · Brain · doi:10.1093/brain/awq033 · Cited by 249
Valenzano, D. R., Benayoun, B. A., Singh, P. P., Zhang, E., Etter, P. D., Hu, C.-K., Clément-Ziza, M., Willemsen, D., Cui, R., Harel, I., et al. (2015) · Cell · doi:10.1016/j.cell.2015.11.008 · Cited by 243
TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers
Finch, N., Carrasquillo, M. M., Baker, M., Rutherford, N. J., Coppola, G., DeJesus-Hernandez, M., Crook, R., Hunter, T., Ghidoni, R., Benussi, L., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e31820a0e3b · Cited by 243
Self-citationTDP-43 is deposited in the Guam parkinsonism-dementia complex brains
Hasegawa, M., Arai, T., Akiyama, H., Nonaka, T., Mori, H., Hashimoto, T., Yamazaki, M., & Oyanagi, K. (2007) · Brain · doi:10.1093/brain/awm065 · Cited by 242
Lysosomal dysfunction in neurodegeneration: emerging concepts and methods
Udayar, V., Chen, Y., Sidransky, E., & Jagasia, R. (2022) · Trends in Neurosciences · doi:10.1016/j.tins.2021.12.004 · Cited by 240
Chen-Plotkin, A. S., Unger, T. L., Gallagher, M. D., Bill, E., Kwong, L. K., Volpicelli-Daley, L., Busch, J. I., Akle, S., Grossman, M., Van Deerlin, V., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.0521-12.2012 · Cited by 230
Selective functional, regional, and neuronal vulnerability in frontotemporal dementia
Seeley, W. W. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3283168e2d · Cited by 240
Snowden, J. S., Thompson, J. C., Stopford, C. L., Richardson, A. M. T., Gerhard, A., Neary, D., & Mann, D. M. A. (2011) · Brain · doi:10.1093/brain/awr189 · Cited by 238
Self-citationRoot, J., Merino, P., Nuckols, A., Johnson, M., & Kukar, T. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105360 · Cited by 238
Neumann, M., Kwong, L. K., Truax, A. C., Vanmassenhove, B., Kretzschmar, H. A., Van Deerlin, V. M., Clark, C. M., Grossman, M., Miller, B. L., Trojanowski, J. Q., et al. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000248554.45456.58 · Cited by 237
Insights into the role of progranulin in immunity, infection, and inflammation
Jian, J., Konopka, J., & Liu, C. (2013) · Journal of Leukocyte Biology · doi:10.1189/jlb.0812429 · Cited by 238
Progranulin protects against amyloid β deposition and toxicity in Alzheimer's disease mouse models
Minami, S. S., Min, S.-W., Krabbe, G., Wang, C., Zhou, Y., Asgarov, R., Li, Y., Martens, L. H., Elia, L. P., Ward, M. E., et al. (2014) · Nature Medicine · doi:10.1038/nm.3672 · Cited by 237
Puschmann, A. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.01.020 · Cited by 238
Clinicopathologic assessment and imaging of tauopathies in neurodegenerative dementias
Murray, M. E., Kouri, N., Lin, W.-L., Jack, C. R., Dickson, D. W., & Vemuri, P. (2014) · Alzheimer's Research & Therapy · doi:10.1186/alzrt231 · Cited by 236
“Over the past 15 years, knowledge about the genetics of familial FTLD research has exploded – yielding the discoveries of mutations in the gene for MAPT [10-12], mutations in the gene encoding progranulin (GRN) [13,14], and recently the abnormal hexanucleotide repeat expansion in the gene C9ORF72 [15,16].”
BackgroundSelf-citationvan Swieten, J. C., & Heutink, P. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70194-7 · Cited by 234
Kwong, L. K., Neumann, M., Sampathu, D. M., Lee, V. M.-Y., & Trojanowski, J. Q. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0226-5 · Cited by 232
The non-fluent/agrammatic variant of primary progressive aphasia
Grossman, M. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70099-6 · Cited by 234
Targeting Neuroinflammation to Treat Alzheimer’s Disease
Ardura-Fabregat, A., Boddeke, E. W. G. M., Boza-Serrano, A., Brioschi, S., Castro-Gomez, S., Ceyzériat, K., Dansokho, C., Dierkes, T., Gelders, G., Heneka, M. T., et al. (2017) · CNS Drugs · doi:10.1007/s40263-017-0483-3 · Cited by 233
Logan, T., Simon, M. J., Rana, A., Cherf, G. M., Srivastava, A., Davis, S. S., Low, R. L. Y., Chiu, C.-L., Fang, M., Huang, F., et al. (2021) · Cell · doi:10.1016/j.cell.2021.08.002 · Cited by 233
Self-citationThe lysosomal function of progranulin, a guardian against neurodegeneration
Paushter, D. H., Du, H., Feng, T., & Hu, F. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1861-8 · Cited by 230
“heterozygous mutations in the GRN gene, resulting in haploinsuffiency, were found to cause frontotemporal lobar degeneration (FTLD) [8, 27, 35, 70, 79, 115].”
Cenik, B., Sephton, C. F., Kutluk Cenik, B., Herz, J., & Yu, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r112.399170 · Cited by 229
Beck, J., Rohrer, J. D., Campbell, T., Isaacs, A., Morrison, K. E., Goodall, E. F., Warrington, E. K., Stevens, J., Revesz, T., Holton, J., et al. (2008) · Brain · doi:10.1093/brain/awm320 · Cited by 230
Kimonis, V. E., Fulchiero, E., Vesa, J., & Watts, G. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2008.09.003 · Cited by 227
Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era
Paez-Colasante, X., Figueroa-Romero, C., Sakowski, S. A., Goutman, S. A., & Feldman, E. L. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.57 · Cited by 225
Progranulin in frontotemporal lobar degeneration and neuroinflammation
Ahmed, Z., Mackenzie, I. R., Hutton, M. L., & Dickson, D. W. (2007) · Journal of Neuroinflammation · doi:10.1186/1742-2094-4-7 · Cited by 224
Self-citationParkinsonism and impaired axonal transport in a mouse model of frontotemporal dementia
Ittner, L. M., Fath, T., Ke, Y. D., Bi, M., van Eersel, J., Li, K. M., Gunning, P., & Götz, J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808084105 · Cited by 223
The Neuronal Ceroid-Lipofuscinoses (Batten Disease)
Mole, S. E., & Haltia, M. (2015) · Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease · doi:10.1016/b978-0-12-410529-4.00070-x · Cited by 220
Lashley, T., Rohrer, J. D., Mead, S., & Revesz, T. (2015) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12250 · Cited by 220
Distinct genetic forms of frontotemporal dementia
Seelaar, H., Kamphorst, W., Rosso, S. M., Azmani, A., Masdjedi, R., de Koning, I., Maat-Kievit, J. A., Anar, B., Kaat, L. D., Breedveld, G. J., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000319702.37497.72 · Cited by 182
CSF biomarkers in frontotemporal lobar degeneration with known pathology
Bian, H., Van Swieten, J. C., Leight, S., Massimo, L., Wood, E., Forman, M., Moore, P., de Koning, I., Clark, C. M., Rosso, S., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000311445.21321.fc · Cited by 216
Rademakers, R., Baker, M., Gass, J., Adamson, J., Huey, E. D., Momeni, P., Spina, S., Coppola, G., Karydas, A. M., Stewart, H., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70221-1 · Cited by 216
Self-citationHoulden, H., Johnson, J., Gardner-Thorpe, C., Lashley, T., Hernandez, D., Worth, P., Singleton, A. B., Hilton, D. A., Holton, J., Revesz, T., et al. (2007) · Nature Genetics · doi:10.1038/ng.2007.43 · Cited by 212
TDP-43 and FUS: a nuclear affair
Dormann, D., & Haass, C. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.05.002 · Cited by 214
ER stress and impaired autophagy flux in neuronal degeneration and brain injury
Yin, Y., Sun, G., Li, E., Kiselyov, K., & Sun, D. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.08.008 · Cited by 211
Microglial Phagocytosis: A Disease-Associated Process Emerging from Alzheimer’s Disease Genetics
Podleśny-Drabiniok, A., Marcora, E., & Goate, A. M. (2020) · Trends in Neurosciences · doi:10.1016/j.tins.2020.10.002 · Cited by 211
Imaging and fluid biomarkers in frontotemporal dementia
Meeter, L. H., Kaat, L. D., Rohrer, J. D., & van Swieten, J. C. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.75 · Cited by 210
Moisse, K., Volkening, K., Leystra-Lantz, C., Welch, I., Hill, T., & Strong, M. J. (2009) · Brain Research · doi:10.1016/j.brainres.2008.10.021 · Cited by 210
Diverse human astrocyte and microglial transcriptional responses to Alzheimer’s pathology
Smith, A. M., Davey, K., Tsartsalis, S., Khozoie, C., Fancy, N., Tang, S. S., Liaptsi, E., Weinert, M., McGarry, A., Muirhead, R. C. J., et al. (2022) · Acta Neuropathologica · doi:10.1007/s00401-021-02372-6 · Cited by 209
Molecular genetics of Alzheimer's disease: An update
Brouwers, N., Sleegers, K., & Van Broeckhoven, C. (2008) · Annals of Medicine · doi:10.1080/07853890802186905 · Cited by 208
Progranulin as a therapeutic target in neurodegenerative diseases
Rhinn, H., Tatton, N., McCaughey, S., Kurnellas, M., & Rosenthal, A. (2022) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2021.11.015 · Cited by 208
Brady, O. A., Zheng, Y., Murphy, K., Huang, M., & Hu, F. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds475 · Cited by 205
Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin
Zhou, X., Sun, L., Bastos de Oliveira, F., Qi, X., Brown, W. J., Smolka, M. B., Sun, Y., & Hu, F. (2015) · Journal of Cell Biology · doi:10.1083/jcb.201502029 · Cited by 203
Neurotransmitter deficits from frontotemporal lobar degeneration
Murley, A. G., & Rowe, J. B. (2018) · Brain · doi:10.1093/brain/awx327 · Cited by 202
Serum biomarker for progranulin‐associated frontotemporal lobar degeneration
Sleegers, K., Brouwers, N., Van Damme, P., Engelborghs, S., Gijselinck, I., van der Zee, J., Peeters, K., Mattheijssens, M., Cruts, M., Vandenberghe, R., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21621 · Cited by 203
Altered Proteins in the Aging Brain
Elobeid, A., Libard, S., Leino, M., Popova, S. N., & Alafuzoff, I. (2016) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlw002 · Cited by 202
Pickering-Brown, S. M., Rollinson, S., Du Plessis, D., Morrison, K. E., Varma, A., Richardson, A. M. T., Neary, D., Snowden, J. S., & Mann, D. M. A. (2008) · Brain · doi:10.1093/brain/awm331 · Cited by 199
Self-citationSnowden, J. S., Pickering-Brown, S. M., Mackenzie, I. R., Richardson, A. M. T., Varma, A., Neary, D., & Mann, D. M. A. (2006) · Brain · doi:10.1093/brain/awl267 · Cited by 200
Self-citationGötzl, J. K., Mori, K., Damme, M., Fellerer, K., Tahirovic, S., Kleinberger, G., Janssens, J., van der Zee, J., Lang, C. M., Kremmer, E., et al. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1262-6 · Cited by 197
Neumann, M., Kwong, L. K., Sampathu, D. M., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Archives of Neurology · doi:10.1001/archneur.64.10.1388 · Cited by 197
Hereditary Frontotemporal Dementia Caused by Tau Gene Mutations
Van Swieten, J., & Spillantini, M. G. (2007) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00052.x · Cited by 195
The molecular basis of the frontotemporal lobar degeneration–amyotrophic lateral sclerosis spectrum
van Langenhove, T., van der Zee, J., & van Broeckhoven, C. (2012) · Annals of Medicine · doi:10.3109/07853890.2012.665471 · Cited by 195
Geser, F., Lee, V. M.-Y., & Trojanowski, J. Q. (2010) · Neuropathology · doi:10.1111/j.1440-1789.2009.01091.x · Cited by 195
Du, X., Wang, J., Zhu, H., Rinaldo, L., Lamar, K.-M., Palmenberg, A. C., Hansel, C., & Gomez, C. M. (2013) · Cell · doi:10.1016/j.cell.2013.05.059 · Cited by 195
Clinical, neuroimaging and neuropathological features of a new chromosome 9p-linked FTD-ALS family
Boxer, A. L., Mackenzie, I. R., Boeve, B. F., Baker, M., Seeley, W. W., Crook, R., Feldman, H., Hsiung, G.-Y. R., Rutherford, N., Laluz, V., et al. (2011) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2009.204081 · Cited by 194
Self-citationIndividuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis
Ward, M. E., Chen, R., Huang, H.-Y., Ludwig, C., Telpoukhovskaia, M., Taubes, A., Boudin, H., Minami, S. S., Reichert, M., Albrecht, P., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aah5642 · Cited by 193
Self-citationRare variant associations with plasma protein levels in the UK Biobank
Dhindsa, R. S., Burren, O. S., Sun, B. B., Prins, B. P., Matelska, D., Wheeler, E., Mitchell, J., Oerton, E., Hristova, V. A., Smith, K. R., et al. (2023) · Nature · doi:10.1038/s41586-023-06547-x · Cited by 193
“We have revised our terminology to use “cis-CDS pQTLs,” “trans-CDS pQTLs,” and “cis-position, trans-CDS pQTLs” to be consistent with prior literature (PMID 35534486).”
ResultAmyotrophic lateral sclerosis, frontotemporal dementia and beyond: the TDP-43 diseases
Geser, F., Martinez-Lage, M., Kwong, L. K., Lee, V. M.-Y., & Trojanowski, J. Q. (2009) · Journal of Neurology · doi:10.1007/s00415-009-5069-7 · Cited by 194
Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome
Masellis, M., Momeni, P., Meschino, W., Heffner, R., Elder, J., Sato, C., Liang, Y., George-Hyslop, P. S., Hardy, J., Bilbao, J., et al. (2006) · Brain · doi:10.1093/brain/awl276 · Cited by 195
Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency
Zhang, J., Velmeshev, D., Hashimoto, K., Huang, Y.-H., Hofmann, J. W., Shi, X., Chen, J., Leidal, A. M., Dishart, J. G., Cahill, M. K., et al. (2020) · Nature · doi:10.1038/s41586-020-2709-7 · Cited by 191
Yu, C.-E., Bird, T. D., Bekris, L. M., Montine, T. J., Leverenz, J. B., Steinbart, E., Galloway, N. M., Feldman, H., Woltjer, R., Miller, C. A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2009.328 · Cited by 190
Self-citationAlteration of behavioural phenotype in mice by targeted disruption of the progranulin gene
Kayasuga, Y., Chiba, S., Suzuki, M., Kikusui, T., Matsuwaki, T., Yamanouchi, K., Kotaki, H., Horai, R., Iwakura, Y., & Nishihara, M. (2007) · Behavioural Brain Research · doi:10.1016/j.bbr.2007.07.020 · Cited by 189
C9orf72 binds SMCR8, localizes to lysosomes, and regulates mTORC1 signaling
Amick, J., Roczniak-Ferguson, A., & Ferguson, S. M. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e16-01-0003 · Cited by 188
Long, J. M., Ray, B., & Lahiri, D. K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.518241 · Cited by 187
Mukherjee, O., Pastor, P., Cairns, N. J., Chakraverty, S., Kauwe, J. S. K., Shears, S., Behrens, M. I., Budde, J., Hinrichs, A. L., Norton, J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20963 · Cited by 187
MicroRNAs in neurodegenerative diseases and their therapeutic potential
Junn, E., & Mouradian, M. M. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.10.002 · Cited by 186
Galantamine in Frontotemporal Dementia and Primary Progressive Aphasia
Kertesz, A., Morlog, D., Light, M., Blair, M., Davidson, W., Jesso, S., & Brashear, R. (2008) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000113034 · Cited by 217
Frontotemporal dementia: latest evidence and clinical implications
Young, J. J., Lavakumar, M., Tampi, D., Balachandran, S., & Tampi, R. R. (2018) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125317739818 · Cited by 186
Targeting microglia for the treatment of Alzheimer’s Disease
Wes, P. D., Sayed, F. A., Bard, F., & Gan, L. (2016) · Glia · doi:10.1002/glia.22988 · Cited by 185
“Progranulin haploinsufficiency is a significant cause of familial frontotemporal lobar dementia (FTLD) associated with mislocalized TAR DNA/RNA binding protein 43 (TDP-43) (FTLD-TDP43) (Baker et al., 2006; Cruts et al., 2006).”
BackgroundA Common Biological Mechanism in Cancer and Alzheimers Disease?
Behrens, M., Lendon, C., & Roe, C. (2009) · Current Alzheimer Research · doi:10.2174/156720509788486608 · Cited by 184
Frontotemporal lobar degeneration
Grossman, M., Seeley, W. W., Boxer, A. L., Hillis, A. E., Knopman, D. S., Ljubenov, P. A., Miller, B., Piguet, O., Rademakers, R., Whitwell, J. L., et al. (2023) · Nature Reviews Disease Primers · doi:10.1038/s41572-023-00447-0 · Cited by 178
Self-citationJosephs, K. A., Ahmed, Z., Katsuse, O., Parisi, J. F., Boeve, B. F., Knopman, D. S., Petersen, R. C., Davies, P., Duara, R., Graff-Radford, N. R., et al. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/nen.0b013e31803020cf · Cited by 183
Self-citationMann, D. M., Rollinson, S., Robinson, A., Bennion Callister, J., Thompson, J. C., Snowden, J. S., Gendron, T., Petrucelli, L., Masuda-Suzukake, M., Hasegawa, M., et al. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-68 · Cited by 182
Self-citationWang, W.-X., Wilfred, B. R., Madathil, S. K., Tang, G., Hu, Y., Dimayuga, J., Stromberg, A. J., Huang, Q., Saatman, K. E., & Nelson, P. T. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.091202 · Cited by 182
Prominent phenotypic variability associated with mutations in Progranulin
Kelley, B. J., Haidar, W., Boeve, B. F., Baker, M., Graff-Radford, N. R., Krefft, T., Frank, A. R., Jack, C. R., Shiung, M., Knopman, D. S., et al. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.08.022 · Cited by 181
Self-citationVercruysse, P., Vieau, D., Blum, D., Petersén, Å., & Dupuis, L. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00002 · Cited by 172
“Mutations inMAPT, encoding Tau, or PGRN, encoding progranulin, cause typical FTD and have never been associated to ALS until now (Baker et al., 2006; van Es et al., 2017).”
BackgroundYin, F., Dumont, M., Banerjee, R., Ma, Y., Li, H., Lin, M. T., Beal, M. F., Nathan, C., Thomas, B., & Ding, A. (2010) · The FASEB Journal · doi:10.1096/fj.10-161471 · Cited by 180
Progranulin regulates lysosomal function and biogenesis through acidification of lysosomes
Tanaka, Y., Suzuki, G., Matsuwaki, T., Hosokawa, M., Serrano, G., Beach, T. G., Yamanouchi, K., Hasegawa, M., & Nishihara, M. (2017) · Human Molecular Genetics · doi:10.1093/hmg/ddx011 · Cited by 180
Ber, I. L., Guedj, E., Gabelle, A., Verpillat, P., Volteau, M., Thomas-Anterion, C., Decousus, M., Hannequin, D., Vera, P., Lacomblez, L., et al. (2006) · Brain · doi:10.1093/brain/awl288 · Cited by 179
Velakoulis, D., Walterfang, M., Mocellin, R., Pantelis, C., & McLean, C. (2009) · British Journal of Psychiatry · doi:10.1192/bjp.bp.108.057034 · Cited by 180
Synaptic dysfunction in progranulin-deficient mice
Petkau, T. L., Neal, S. J., Milnerwood, A., Mew, A., Hill, A. M., Orban, P., Gregg, J., Lu, G., Feldman, H. H., Mackenzie, I. R. A., et al. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.10.016 · Cited by 173
Self-citationLudolph, A. C., Kassubek, J., Landwehrmeyer, B. G., Mandelkow, E., Mandelkow, E. ‐., Burn, D. J., Caparros‐Lefebvre, D., Frey, K. A., De Yebenes, J. G., Gasser, T., et al. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2008.02513.x · Cited by 172
Self-citationShankaran, S. S., Capell, A., Hruscha, A. T., Fellerer, K., Neumann, M., Schmid, B., & Haass, C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m705115200 · Cited by 170
TDP-43 frontotemporal lobar degeneration and autoimmune disease
Miller, Z. A., Rankin, K. P., Graff-Radford, N. R., Takada, L. T., Sturm, V. E., Cleveland, C. M., Criswell, L. A., Jaeger, P. A., Stan, T., Heggeli, K. A., et al. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2012-304644 · Cited by 170
Self-citationExosomes: Origins and Therapeutic Potential for Neurodegenerative Disease
Sarko, D. K., & McKinney, C. E. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00082 · Cited by 170
Metadata
- Authors
- Baker, M., Mackenzie, I. R., Pickering-Brown, S. M., Gass, J., Rademakers, R., Lindholm, C., Snowden, J., Adamson, J., Sadovnick, A. D., Rollinson, S., Cannon, A., Dwosh, E., Neary, D., Melquist, S., Richardson, A., Dickson, D., Berger, Z., Eriksen, J., Robinson, T., Zehr, C., Dickey, C. A., Crook, R., McGowan, E., Mann, D., Boeve, B., Feldman, H., & Hutton, M.
- Affiliations
- Mayo Clinic in Florida (US)
- University of Manchester (GB)
- University of British Columbia (CA)
- Mayo Clinic (US)
- Corresponding author
- Mackenzie, Ian R.
- Hutton, Mike
- ORCID
- Baker, Matt
- Mackenzie, Ian R.
- Pickering-Brown, Stuart M.
- Gass, Jennifer
- Rademakers, Rosa
- Snowden, Julie
- Sadovnick, A. Dessa
- Rollinson, Sara
- Cannon, Ashley
- Dwosh, Emily
- Neary, David
- Melquist, Stacey
- Richardson, Anna
- Dickson, Dennis
- Berger, Zdenek
- Eriksen, Jason
- Dickey, Chad A.
- Crook, Richard
- McGowan, Eileen
- Mann, David
- Boeve, Bradley
- Feldman, Howard
- Venue
- Nature
- Published
- 2006-07-16
- Volume
- 442
- Issue
- 7105
- Pages
- 916-919
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2027460468
- Cited by
- 2,058
- References
- 31
- Citations by year
- 2026: 56 · 2025: 77 · 2024: 102 · 2023: 94 · 2022: 93 · 2021: 115 · 2020: 89 · 2019: 114 · 2018: 88 · 2017: 109 · 2016: 103 · 2015: 81 · 2014: 89 · 2013: 107 · 2012: 110
- FWCI
- 86.83
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Clinical Neurology › Amyotrophic Lateral Sclerosis Research
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Keywords
- progranulin, frontotemporal dementia, chromosome 17q21, MAPT, ubiquitin-positive inclusions, neuronal intranuclear inclusions, neurodegeneration, familial dementia, null alleles, growth factors, FTDP-17
- MeSH terms
- Progranulins, Cell Survival, Chromosomes, Human, Pair 17, Dementia, Frontal Lobe, Humans, Genetic Linkage, Mutation, Neurons, Protein Precursors, RNA, Messenger, Temporal Lobe, tau Proteins, Codon, Terminator, Physical Chromosome Mapping, RNA Stability, Intercellular Signaling Peptides and Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.